Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Ribupatide

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apn

Fujian Shengdi Pharmaceutical Co · Phase 3 · Active, not recruiting · Enrollment 144

NCT06994650

No selected arm has a reported week for this endpoint.

    A solid line connects the weeks the source reports.